Pipeline

Clinical Pipeline

Products PC phaseⅠ phaseⅡ phaseⅢ
VB-111
Non-replicating Adeno 5 vector
Ovarian cancer(USA/Israel/EU/Japan)
Combination therapy with Paclitaxel
Co-Development
Partner:VBL(Israel)
rGBM
Investigator-initiated(USA)
Colorectal Cancer
Operation by NCI/VBL(USA)
ENT103
ENT product
Otitis media(Japan)
Co-Development
Partner:CEOLIA PHARMA(Japan)
NC-6004
Cisplatin micelle
Head and Neck cancer(EU/Taiwan)
Combination therapy with Kyet ruda®
Co-Development
Partner:Orient Europharma(Taiwan)
NC-6300
Epirubicin micelle
Soft tissue sarcoma(USA)
In-House Development
FDA Orphan drug designation
NC-6100
PRDM14 (siRNA)
HER2-negative breast cancer
(Japan)
Investigator-initiated
TUG1 (ASO)
GBM (Japan)
Collaboration with NAGOYA University
RUNX1 (mRNA)
Osteo arthritis
(Japan)
PrimRNA
Partner:Axcelead Inc.